Source: Eur Respir Monogr 2012; 57: 161-165
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Jérôme Le Pavec, David Montani, Peter Dorfmüller, Dermot S. O&Callaghan, Marc Humbert, Abdellatif Tazi. Pulmonary hypertension in pulmonary Langerhans’ cell histiocytosis. Eur Respir Monogr 2012; 57: 161-165

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary hypertension in orphan lung diseases Source: Eur Respir Mon 2011; 54: 317-331 Year: 2011 Clinical study of pulmonary hypertension complicating pulmonary Langerhans cell histiocytosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease I Year: 2012 Pulmonary Langerhans' cell histiocytosis Source: Respipedia Article Year: 2016 Pulmonary Langerhans‘ cell histiocytosis (PLCH). Report of two cases diagnosed with pulmonary vascular involvement via exercise tests Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease Year: 2008 Lung transplantation for pulmonary Langerhans‘ cell histiocytosis Source: Eur Respir J 2005; 26: Suppl. 49, 635s Year: 2005 Management of end-stage sarcoidosis: pulmonary hypertension and lung transplantation Source: Eur Respir J 2012; 39: 1520-1533 Year: 2012 Rare indications for lung transplantation Source: Eur Respir Mon 2011; 54: 332-340 Year: 2011 Influence of pregnancy on pulmonary function in women with pulmonary Langerhans cell histiocytosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity Source: Eur Respir J 2005; 26: 586-593 Year: 2005 Smoking-related interstitial lung diseases: a concise review Source: Eur Respir J 2001; 17: 122-132 Year: 2001 Adult pulmonary Langerhans‘ cell histiocytosis and lung cancer Source: Annual Congress 2009 - Clinical aspects and epidemiology in lung cancer Year: 2009 Pneumothorax in pulmonary langerhans cell histiocytosis (PLCH) Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children Year: 2018 Ventilation disorders dynamics and morphological changes in patients with pulmonary Langerhans cell histiocytosis (PLCH) Source: International Congress 2015 – IIPs: orphan Year: 2015 Pulmonary hypertension in interstitial lung diseases Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease Year: 2009 Baseline characteristics and survival of patients with pulmonary hypertension in interstitial lung disease in the “HYPID” study Source: Annual Congress 2013 –Pulmonary circulation: clinical physiology Year: 2013 Pulmonary hypertension in patients with interstitial lung disease Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases Year: 2011 Pulmonary hypertension due to lung disease Source: International Congress 2017 – Russian Programme 2017 Year: 2017 Pulmonary hypertension in lymphangioleiomyomatosis: characteristics in 20 patients}, Source: Eur Respir J 2012; 40: 630-640 Year: 2012 Pulmonary hypertension in interstitial lung disease Source: Eur Respir J 2008; 31: 1357-1367 Year: 2008 Pulmonary hypertension in sickle cell disease Source: Annual Congress 2007 - ACCP1 - Pulmonary hypertension in sickle cell disease Year: 2007